Novel recessive mutations in MSTO1 cause cerebellar atrophy with pigmentary retinopathy.
Kazuhiro IwamaToru TakaoriAi FukushimaJun TohyamaAkihiko IshiyamaChihiro OhbaSatomi MitsuhashiSatoko MiyatakeAtsushi TakataNoriko MiyakeShuichi ItoHirotomo SaitsuTakeshi MizuguchiNaomichi MatsumotoPublished in: Journal of human genetics (2018)
Misato 1, mitochondrial distribution and morphology regulator (encoded by the MSTO1 gene), is involved in mitochondrial distribution and morphology. Recently, MSTO1 mutations have been shown to cause clinical manifestations suggestive of mitochondrial dysfunction, such as muscle weakness, short stature, motor developmental delay, and cerebellar atrophy. Both autosomal dominant and recessive modes of inheritance have been suggested. We performed whole-exome sequencing in two unrelated patients showing cerebellar atrophy, intellectual disability, and pigmentary retinopathy. Three novel mutations were identified: c.836 G > A (p.Arg279His), c.1099-1 G > A (p.Val367Trpfs*2), and c.79 C > T (p.Gln27*). Both patients had compound heterozygous mutations with a combination of protein-truncation mutation and missense mutation, the latter shared by them both. This survey of two patients with recessive and novel MSTO1 mutations provides additional clinical and genetic information on the pathogenicity of MSTO1 in humans.
Keyphrases
- intellectual disability
- end stage renal disease
- autism spectrum disorder
- newly diagnosed
- chronic kidney disease
- prognostic factors
- oxidative stress
- healthcare
- peritoneal dialysis
- early onset
- genome wide
- transcription factor
- small molecule
- patient reported outcomes
- cystic fibrosis
- health information
- genome wide identification